000			03188nam a22003377a 4500
999			_c12256 _d12256
001			MT 2022 0020
003			PILC
005			20240720153241.0
008			220407b xxu||||| |||| 00| 0 eng d
040			_beng _cFEU-NRMF MEDICAL LIBRARY _erda
041			_aenglish
050			_aMT 2022 0020
245			_aCovid-19 analysis : _ba scoping review of its role in erythrocyte function / _cRikki Francis R. Bagang, Claudette Jane L. Bangloy, Raphaella Jenna T. Bayan, Christine Kyle S. Dalisay, Rafael Rene G. Macaspac, Jose Danilo B. Manalang, Patricia Hope J. Paler, Sophia Elaine M. Turalde; TJ R. Jaula.
260			_aFairview, Quezon City: _bSchool of Medical Technology, FEU-NRMF, _c2022.
300			_a97 pages: _billustrations, tables; _c28 cm.
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
504			_aIncludes bibliographical references.
520			_aAbstract: COVID-19, a disease caused by SARS-CoV-2, is known for its spectrum of clinical manifestations affecting respiratory system. The emergence of COVID-19 led to the production of different studies. However, existing investigations showed insufficient on how COVID-19 affects erythrocytes despite its potential effects on the disease. With that, this paper employed a scoping review on how COVID-19 affects erythrocytes, specifically how these cells contribute to the severity and hypoxic progression of the disease. Collected studies are those published from December 2019 to December 2021 from databases, namely WHO COVID-19 Database, PubMed (MEDLINE), Global Index Medicus and Google Scholar. Most studies collected are review articles, while clinical studies, case reports and the like are still lacking. The findings indicate that the role of ACE-2 is significantly accountable for the link between COVID-19 and erythrocytes, thereby leading to a series of related events. Hypoxia, one of the disease's main presentations, was analyzed to play a pivotal role in the exchanging effect of COVID-19 and erythrocytes on each other. All of which permits the progression of hypoxia due to problems in blood flow, oxygen transportation and immune response, leading to blood disorders or aggravating an existing blood disorder. Although studies collected were chiefly limited to review articles, the authors were able to maximize all sources to map the key points and arrive with an analysis that achieves the objectives of the study. Moreover, the authors have analyzed the heightened need for extensive research by utilizing first-hand patient data - increasing the production of clinical studies, case reports and the like to strengthen and widen the information on how COVID-19 and erythrocytes are associated with one another.
521			_aTHMT
700			_aBagang, Rikki Francis R. _eauthor
700			_aBangloy, Claudette Jane L. _eauthor
700			_aBayan, Raphaella Jenna T. _eauthor
700			_aDalisay, Christine Kyle S. _eauthor
700			_aMacaspac, Jose Danilo B. _eauthor
700			_aPaler, Patricia Hope J. _eauthor
700			_aTuralde, Sophia Elaine M. _eauthor
700			_aJaula, TJ R., RMT _eadviser
942			_2lcc _cRU